Posted by Michael Wonder on 25 Mar 2019
EMA publishes agenda for 25-28 March CHMP meeting
25 March 2019 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Turoctocog alfa pegol
- Angiotensin II
- Ciprofloxacin
- L-lysine hydrochloride with L-arginine hydrochloride
- Botulinum toxin type A
- Posaconazole
- Larotrectinib
